companydata.dkInnosurge Biologics A/S: Financial statements 2022
CVR: 38768964
Innosurge Biologics A/S (CVR 38768964) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,183,245 and a net result of DKK 489,687 compared with DKK -613,437 the year before. That is an increase of 119.9% compared with the year before. Equity amounted to DKK 1,326,069. The solvency ratio was 28.5%. The company had 3 employees in the financial year.
- Gross Profit
- 2,183,245 kr.
- Profit/Loss
- 489,687 kr.
- Equity
- 1,326,069 kr.
- Total Assets
- 4,647,398 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 2.2 mio. | 490 t. | 1.3 mio. | 3 |
| 2021 | - | 993 t. | -613 t. | 836 t. | 3 |
| 2020 | - | -695 t. | -2.6 mio. | 1.4 mio. | 3 |
| 2019 | - | 1.2 mio. | 290 t. | 2 mio. | 2 |
| 2018 | - | 1.7 mio. | 799 t. | 1.8 mio. | 1 |
Keep an eye on Innosurge Biologics A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Innosurge Biologics A/S has published its annual report for 2021. Gross profit came to DKK 992,732, and the net result was DKK -613,437.
About Innosurge Biologics A/S
Innosurge Biologics A/S is a Danish company of the type Aktieselskab based in Randers NV, founded in 2017. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Peter Møller Lassen. The company is owned by CMA HOLDING RANDERS ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 4,455,235 and a net result of DKK 1,662,593 compared with DKK 251,617 the year before. Equity amounted to DKK 2,897,096.